SarCode draws in $7M for inflammation drugs
October 22, 2007 | David P. Hamilton
See our story on this San Francisco biotech in today’s daily briefing at VentureBeat Life Sciences.
Next Story: EditGrid syncs with Excel, useful for serious number-crunchers
Previous Story: Auctomatic launches better tools for eBay powersellers
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.












